Cancer Drug Parity Act of 2026 Legislation by Sen. Smith Analyzed
Bill Intros-Senate
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-07-25
Bailey Malota
WASHINGTON, July 25 -- The Cancer Drug Parity Act of 2026, originally introduced by Sen. Tina Smith, D-Minnesota, on July 15, 2026, has been analyzed by the Congressional Research Service. This legislation aims to ensure that health insurance plans provide equitable cost-sharing for oral anticancer drugs, matching the financial terms for those administered by healthcare providers.
The bill addresses a pressing concern in cancer care: the disparity in patient costs associated with di . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, July 25 -- The Cancer Drug Parity Act of 2026, originally introduced by Sen. Tina Smith, D-Minnesota, on July 15, 2026, has been analyzed by the Congressional Research Service. This legislation aims to ensure that health insurance plans provide equitable cost-sharing for oral anticancer drugs, matching the financial terms for those administered by healthcare providers.
The bill addresses a pressing concern in cancer care: the disparity in patient costs associated with di . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
